Work

141P Soft tissue sarcoma: A real-world analysis in a tertiary care centre from Northeast India

Year: 2025

Type: article

Abstract: Soft tissue sarcomas (STSs), accounting for ∼1% of all cancers, encompass a heterogeneous group of histopathological subtypes. Outcomes are notably improved following complete surgical resection, with perioperative radiotherapy and/or chemotherapy enhancing disease-free survival (DFS) and overall survival (OS). Despite these advancements, the 5-year survival probability remains around 50%. Advanced STSs demonstrate poor chemotherapy response, with short progression-free survival and OS typically <2 years.

Source: ESMO Open

DOI: 10.1016/j.esmoop.2025.104454

Authors: P.S. Roy, A. Bhattacharyya, A. Kalita, G. Das, L. Kakoti

Institution: Bhubaneswar Borooah Cancer Institute

Language: English

Topic: Sarcoma Diagnosis and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $3,910